TY - JOUR
T1 - Crystallographic structures of two bisphosphonate:1-deoxyxylulose-5- phosphate reductoisomerase complexes
AU - Yajima, Shunsuke
AU - Hara, Kodai
AU - Sanders, John M.
AU - Yin, Fenglin
AU - Ohsawa, Kanju
AU - Wiesner, Jochen
AU - Jomaa, Hassan
AU - Oldfield, Eric
PY - 2004/9/8
Y1 - 2004/9/8
N2 - We have obtained the single-crystal X-ray crystallographic structures of the bisphosphonates [(1-isoquinolinylamino)methylene]-1,1-bisphosphonate and [[(5-chloro-2-pyridinyl)amino]methylene]-1,1-bisphosphonate, bound to the enzyme 1-deoxyxylulose-5-phosphate reductoisomerase (DXR, EC 1.1.1.267, also known as 2-C-methyl-d-erythritol-4-phosphate synthase), an important target for the development of antimalarial drugs. Our results indicate that both bisphosphonates bind into the fosmidomycin binding site. The aromatic groups are in a shallow hydrophobic pocket, and the phosphonate groups are involved in electrostatic interactions with Mg2+ or a cluster of carboxylic acid groups and lysine while the fosmidomycin phosphonate-binding site is occupied by a sulfate ion (as also observed in the DXR/NADP+ structure). The availability of these two new crystal structures opens up the possibility of the further development of bisphosphonates and related systems as DXR inhibitors and, potentially, as antiinfective agents.
AB - We have obtained the single-crystal X-ray crystallographic structures of the bisphosphonates [(1-isoquinolinylamino)methylene]-1,1-bisphosphonate and [[(5-chloro-2-pyridinyl)amino]methylene]-1,1-bisphosphonate, bound to the enzyme 1-deoxyxylulose-5-phosphate reductoisomerase (DXR, EC 1.1.1.267, also known as 2-C-methyl-d-erythritol-4-phosphate synthase), an important target for the development of antimalarial drugs. Our results indicate that both bisphosphonates bind into the fosmidomycin binding site. The aromatic groups are in a shallow hydrophobic pocket, and the phosphonate groups are involved in electrostatic interactions with Mg2+ or a cluster of carboxylic acid groups and lysine while the fosmidomycin phosphonate-binding site is occupied by a sulfate ion (as also observed in the DXR/NADP+ structure). The availability of these two new crystal structures opens up the possibility of the further development of bisphosphonates and related systems as DXR inhibitors and, potentially, as antiinfective agents.
UR - http://www.scopus.com/inward/record.url?scp=4444236556&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=4444236556&partnerID=8YFLogxK
U2 - 10.1021/ja040126m
DO - 10.1021/ja040126m
M3 - Article
C2 - 15339150
AN - SCOPUS:4444236556
SN - 0002-7863
VL - 126
SP - 10824
EP - 10825
JO - Journal of the American Chemical Society
JF - Journal of the American Chemical Society
IS - 35
ER -